Corrigendum to “The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases”

Table 1

The regulators of ovotransferrin and ovotransferrin-derived peptides and adjusting effect.

Bioactive peptide	Regulated factor	The result of adjustment	Reference
IRW	Angiotensin II	Inhibited the migration of vascular smooth muscle cells	[52]
IRW	ACE inhibition and endothelial nitric oxide synthase	Antihypertensive effects	[45]
IRW and IQW	Tumor necrosis factor (TNF)	Reducing endothelial inflammation and oxidative stress	[43]
Ovotransferrin	Reactive oxygen species	Antioxidants and oxygen radical-scavenging effects	[53]
IRW	ACE2, ICAM-1, and VCAM-1	Increased ACE2 and decreased proinflammatory genes expression	[31]